A Qualitative Study on Barriers to Treatment and Control of Hypertension Among Patients at Dessie Referral Hospital, Northeast Ethiopia, Ethiopia: Healthcare Workers’ Perspective

References

• World Health Organization. Global Health Risks; Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
   Google Scholar
• Shrestha S, Shrestha A, Koju RP, et al. Barrier and facilitators to treatment among newly diagnosed hypertensive patients in Nepal: a Qualitative Study. Heart Asia. 2018;7(34):1–11.
   Google Scholar
• Okwuonu CG, Emmanuel CI, Ojimadu NE. Perception and practice of lifestyle modification in the management of hypertension among hypertensives in south-east Nigeria. Int J Med Biomed Res. 2014;3(2):121–131.
   Google Scholar
• Bhandari B, Bhattarai M, Ghimire A, Pokharel P. Adherence to antihypertensive medications: population based follow up in adherence to antihypertensive medications: population based follow up in Eastern Nepal. J Nepal Health Res Counc. 2015;13(29):38–42.
   PubMedGoogle Scholar
• Okai DE, Manu A, Amoah EM, Laar A, Akamah J, Torpey K. Patient-level factors influencing hypertension control in adults in Accra, Ghana. BMC Cardiovasc Disord. 2020;20(1):123. doi:10.1186/s12872-020-01370-y
   PubMed Web of Science ®Google Scholar
• Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–222. doi:10.1016/S0140-6736(05)17741-1
   PubMed Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968. doi:10.1001/jama.2013.184182
   PubMed Web of Science ®Google Scholar
• Saju MD, Allagh KP, Scaria L, Joseph S, Thiyagarajan JA. Prevalence, awareness, treatment, and control of hypertension and its associated risk factors: results from baseline survey of SWADES Family Cohort Study. Int J Hypertens. 2020;2020:1–7. doi:10.1155/2020/4964835
   Web of Science ®Google Scholar
• Vrijens B, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;1–6. doi:10.1136/bmj.39416.559942.BE
   Web of Science ®Google Scholar
• Al-Ramahi R. Adherence to medications and associated factors: a cross-sectional study among Palestinian hypertensive patients. J Epidemiol Glob Health. 2014;5(2):125. doi:10.1016/j.jegh.2014.05.005
   PubMedGoogle Scholar
• Tsadik DG, Berhane Y, Worku A. Adherence to antihypertensive treatment and associated factors in central Ethiopia. Int J Hypertens. 2020;2020:10–13.
   Web of Science ®Google Scholar
• Vedanthan R, Tuikong N, Kofler C, et al. Barriers and facilitators to nurse management of hypertension: a qualitative analysis from Western Kenya. Ethn Dis. 2016;26(3):315–322. doi:10.18865/ed.26.3.315
   PubMed Web of Science ®Google Scholar
• Park JE, Park J, Chang SJ, Lee JH, Kim SY. The determinants of and barriers to awareness and treatment of hypertension in the Korean Population. Asia Pac J Public Health. 2019;31(2):121–135.
   PubMed Web of Science ®Google Scholar
• Jolles EP, Padwal RS, Clark AM, Braam B. A qualitative study of patient perspectives about hypertension. Hypertension. 2013;2013. doi:10.5402/2013/671691
   Google Scholar
• Shima R, Farizah MH, Majid HA. A qualitative study on hypertensive care behavior in primary health care settings in Malaysia. Patient Prefer Adherence. 2014;8:1597–1609. doi:10.2147/PPA.S69680
   PubMed Web of Science ®Google Scholar
• Malik A, Yoshida Y, Erkin T, Salim D, Hamajima N. Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. J Med Sci. 2014;76:255–263.
   Google Scholar
• Boima V, Ademola AD, Odusola AO, et al. Factors associated with medication nonadherence among hypertensives in Ghana and Nigeria. Int J Hypertens. 2015;2015:1–8. doi:10.1155/2015/205716
   Web of Science ®Google Scholar
• Muhamedhussein MS, Nagri ZI, Manji KP. Prevalence, risk factors, awareness, and treatment and control of hypertension in Mafia Island, Tanzania. Int J Hypertens. 2016;2016:1–5. doi:10.1155/2016/1281384
   Web of Science ®Google Scholar
• Ambaw AD, Alemie GA, Yohannes SMW, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12(1):1. doi:10.1186/1471-2458-12-282
   Web of Science ®Google Scholar
• Saleem F, Ma H, Aa S, Atif M. Drug attitude and adherence: a qualitative insight of patients with hypertension. J Young Pharm. 2012;4(2):101–107. doi:10.4103/0975-1483.96624
   PubMedGoogle Scholar
• Pirasath S, Kumanan T, Guruparan M. A study on knowledge, awareness, and medication adherence in patients with hypertension from a tertiary care centre from northern Sri Lanka. Int J Hypertens. 2017;2017:1–6. doi:10.1155/2017/9656450
   Web of Science ®Google Scholar
• Ali MA, Bekele ML, Teklay G. Antihypertensive medication non-adherence and its determinants among patients on follow up in public hospitals in Northern Ethiopia. Int J Clin Trials. 2014;1(3):95–104. doi:10.5455/2349-3259.ijct20141103
   Google Scholar
• Chelkeba L, Dessie S. Antihypertension medication adherence and associated factors at Dessie. Int J Res Med Sci. 2013;1(3):125–127. doi:10.5455/2320-6012.ijrms20130802
   Google Scholar
• Wake AD, Tuji TS, Sime AT, Mekonnin MT, Taji TM, Hussein AA. Medications, and associated factors among hypertensive patients in a follow-up clinic at asella referral and teaching hospital, Ethiopia: a Cross-Sectional Study. Int J Hypertens. 2021;2021:1–10. doi:10.1155/2021/7359318
   Web of Science ®Google Scholar
• Andualem A, Liknaw T, Edmealem A, Gedefaw M. Adherence to antihypertensive medications among adult hypertensive patients attending chronic follow-up units of Dessie referral hospital, Northeastern Ethiopia. Medicine. 2021;100(31):e26818. doi:10.1097/MD.0000000000026818
   Web of Science ®Google Scholar
• Andualem A, Gelaye H, Damtie Y. Adherence to lifestyle modifications and associated factors among adult hypertensive patients attending chronic follow-up units of Dessie referral hospital, north east Ethiopia. Integr Blood Press Control. 2020;2015:145–156. doi:10.2147/IBPC.S275575
   Web of Science ®Google Scholar
• Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10(8):1–5. doi:10.1111/j.1751-7176.2008.08329.x
   Web of Science ®Google Scholar
• Gebrezgi MT, Trepka MJ, Kidane EA, Gebrezgi MT, Trepka MJ, Kidane EA. Barriers to and facilitators of hypertension management in Asmara, Eritrea: patients’ perspectives. J Health Popul Nutr. 2017;36(1):11. doi:10.1186/s41043-017-0090-4
   PubMed Web of Science ®Google Scholar
• Gupta S, Dhamija JP, Mohan I, Gupta R. Qualitative study of barriers to adherence to antihypertensive medication among rural women in India. Int J Hypertens. 2019;2019:1–7. doi:10.1155/2019/5749648
   Web of Science ®Google Scholar
• Johnson HM, Warner RC, Bartels CM, Lamantia JN. “They’ re younger … it’ s harder.” Primary providers’ perspectives on hypertension management in young adults: a multicenter qualitative study. BMC Res Notes. 2017;1–9. doi:10.1186/s13104-016-2345-3
   Google Scholar
• Howes F, Hansen E, Williams D, Nelson M. Barriers to diagnosing and managing hypertension A qualitative study in Australian general practice. Aust Fam Physician. 2010;39(7):511–516.
   PubMed Web of Science ®Google Scholar
• Hong SH, Wang J, Tang J. Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy. Am J Hypertens. 2013;26(7):879–887. doi:10.1093/ajh/hpt035
   PubMed Web of Science ®Google Scholar